V04 Logo Pill - yellow oval
Generic Name: nevirapine
Pill with imprint V04 Logo is Yellow, Oval and has been identified as Viramune XR 400 mg. It is supplied by Boehringer Ingelheim Pharmaceuticals, Inc.
Viramune XR is used in the treatment of HIV Infection and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Viramune XR 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for V04 Logo
Viramune XR
- Generic Name
- nevirapine
- Imprint
- V04 Logo
- Strength
- 400 mg
- Color
- Yellow
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- NNRTIs
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Boehringer Ingelheim Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 00597-0123 (Discontinued)
See also:
Biktarvy
Biktarvy is a complete HIV-1 treatment in a once-a-day single tablet containing three antiviral ...
Descovy
Descovy is used to treat and prevent HIV infection in adults and adolescents. When used for HIV-1 ...
Cabenuva
Cabenuva (cabotegravir and rilpivirine) injections are a long-acting HIV treatment used to keep HIV ...
Dovato
Dovato is a complete HIV-1 treatment regimen in one tablet that may be used in adults and children ...
Truvada
Truvada is used to prevent HIV (HIV PrEP) or treat HIV-1 infection in combination with other HIV-1 ...
Atripla
Atripla prevents the human immunodeficiency virus (HIV) from reproducing in your body. Learn about ...
Isentress
Isentress is used to treat HIV, which causes acquired immunodeficiency syndrome (AIDS). Learn about ...
Viread
Viread (tenofovir) is used to treat HIV, which causes the acquired immunodeficiency syndrome ...
Apretude
Apretude is used to prevent HIV (HIV PrEP) in adults and adolescents weighing at least 77 pounds ...
More about Viramune XR (nevirapine)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: NNRTIs
- Breastfeeding
Patient resources
Professional resources
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.